Published in Lab Business Week, November 19th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Threshold Pharmaceuticals.
Report 1: Threshold Pharmaceuticals, Inc. (THLD), announced that Alan Colowick has resigned as chief medical officer and will become a consultant to the company and a member of the scientific advisory board. Colowick joined the company in January 2005.
As a consultant, Colowick will continue to provide strategic input and work closely with the company in an advisory role in executing the company's ongoing clinical studies. In the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.